Ovaprene phase 1: protocol finalization, regulatory approval, start-up, and commencement of recruitment, screening, and enrollment for the ovaprene vaginal device clinical trial
Ended Awarded Last action
- Contract number
- 75N94023F00001
- Awardee
-
The Regents Of The University Of California. San Francisco UEI KMH5K9V7S518 Part of State Of California Controllers Office
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Obligated
- $37,778
Award facts
- Contract value 100% obligated
- $37,777.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 16 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- San Francisco, CA 94143, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$6,087 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $43,865 |
About this award
The Regents of the University of California, San Francisco (UCSF) received a delivery order valued at $37,777.78 from the National Institute of Child Health and Human Development (NICHD) for Phase 1 of the OVAPRENE clinical trial. This task order covers protocol finalization, regulatory approval, start-up activities, and commencement of recruitment, screening, and enrollment for the OVAPRENE vaginal device clinical trial. The contract was awarded on September 28, 2023, with an ultimate completion date of October 1, 2024, and utilizes a cost no-fee pricing structure. The work is being performed in San Francisco, California, and no set-aside designation was applied to this award.
This delivery order is issued under a larger contract vehicle and represents UCSF's continuation of its substantial partnership with the National Institutes of Health on clinical research initiatives. UCSF, as a prominent academic medical center and research institution, brings extensive capabilities in clinical translational studies and complex federal contract execution. The award aligns with NICHD's mission to support research and clinical investigations related to child health and human development, leveraging UCSF's established expertise in managing federally-funded clinical trials and regulatory compliance processes.
Quick answers
Who was awarded contract 75N94023F00001?
75N94023F00001 was awarded to The Regents Of The University Of California. San Francisco by National Institute of Child Health and Human Development (National Institutes of Health) on September 28, 2023.
How much is contract 75N94023F00001 worth?
The government has obligated $37,778 on 75N94023F00001.
Is contract 75N94023F00001 an order under another contract?
Yes. 75N94023F00001 is a delivery order under 75N94020D00014, an indefinite delivery contract.
Was contract 75N94023F00001 competed?
The extent of competition for 75N94023F00001 was full and open competition. The government received 16 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award